![Jim Ziegler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jim Ziegler
Corporate Officer/Principal bei
ASCENTAGE PHARMA GROUP INTERNATIONAL
Vermögen: 129 000 $ am 31.07.2026
Profil
Jim Ziegler is currently Chief Commercial Officer at Ascentage Pharma Group International Co., Ltd. Former jobs include Head-Sales & Marketing at Amgen, Inc., VP-Cardiopulmonary & Inflammation at Gilead Sciences, Inc., Head-Sales & Marketing at Pfizer Inc., Head-Sales & Marketing at Biogen, Inc., Vice President-Sales & Marketing at Nodality, Inc., Principal at The United States Army (District of Columbia), Executive Vice President-Commercial at Iovance Biotherapeutics, Inc., and Chief Commercial Officer & Executive VP at Geron Corp.
Education includes an MBA from The University of Chicago and an undergraduate degree from US Military Academy.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GERON CORPORATION 0,02 % | 26.03.2026 | 100 000 ( 0,02 % ) | 129 000 $ | 31.07.2026 |
Aktive Positionen von Jim Ziegler
| Unternehmen | Position | Beginn |
|---|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Corporate Officer/Principal | 02.08.2026 |
Ehemalige bekannte Positionen von Jim Ziegler
| Unternehmen | Position | Ende |
|---|---|---|
| GERON CORPORATION | Corporate Officer/Principal | - |
The United States Army (District of Columbia)
 The United States Army (District of Columbia) SovereignGovernment Engages in army operations | Corporate Officer/Principal | - |
| IOVANCE BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | - |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| BIOGEN INC. | Vertrieb & Marketing | - |
Ausbildung von Jim Ziegler
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
17
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Nodality, Inc.
 Nodality, Inc. BiotechnologyHealth Technology Develops bioinformatics tools to enhance drug development process | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Military Academy
 US Military Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The United States Army (District of Columbia)
The United States Army (District of Columbia) SovereignGovernment Engages in army operations | Government |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Ascentage Pharma Group International Co., Ltd.
 Ascentage Pharma Group International Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering, developing and commercializing of therapies for hematological malignancies | Health Technology |
